m6A RNA modifications: Key regulators of normal and malignant hematopoiesis. (2022)
Attributed to:
Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.exphem.2022.04.006
PubMed Identifier: 35487293
Publication URI: http://europepmc.org/abstract/MED/35487293
Type: Journal Article/Review
Volume: 111
Parent Publication: Experimental hematology
ISSN: 0301-472X